RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Recordati Industria Chimica e Farmaceutica SpA Stock

Recordati Industria Chimica e Farmaceutica SpA Equity 2025

Recordati Industria Chimica e Farmaceutica SpA Equity

1.69 B EUR

Ticker

REC.MI

ISIN

IT0003828271

WKN

A0EABR

In 2025, Recordati Industria Chimica e Farmaceutica SpA's equity was 1.69 B EUR, a 9.06% increase from the 1.55 B EUR equity in the previous year.

Recordati Industria Chimica e Farmaceutica SpA Aktienanalyse

What does Recordati Industria Chimica e Farmaceutica SpA do?

Recordati Industria Chimica e Farmaceutica SpA is an Italian pharmaceutical company based in Milan. The company was founded in 1926 by Giovanni Recordati and now has branches in many countries worldwide. Recordati's business model is based on the development, production, and marketing of drugs for various therapeutic areas. The company focuses particularly on therapy areas such as cardiology, urology, gastroenterology, pneumology, and hematology. Recordati operates in four business areas: Innovative Medicines, OTC Medicines, Generics, and Licensed Products. In the area of innovative medicines, the company specializes in the development of new active substances for the treatment of rare diseases. In the OTC Medicines area, Recordati specializes in the manufacture and marketing of over-the-counter drugs used to treat mild to moderate complaints. The generics area includes the production and marketing of generic products with the aim of influencing price development in the market. In the Licensed Products area, Recordati collaborates with other companies and takes over the marketing of their products in certain regions. Some of Recordati's best-known products include Cariprazine (an antipsychotic), Urolith (a preventive treatment for kidney stones), Zanipress (a treatment for hypertension), and Fokusin (a treatment for benign prostatic hyperplasia). Recordati is also committed to improving access to life-saving medications worldwide. The company engages in collaborations with international organizations such as the Global Alliance for TB Drug Development and supports the WHO's "Target Product Profiles" initiative. In 2019, Recordati Industria Chimica e Farmaceutica SpA achieved sales of around 1.4 billion euros in over 90 countries. The company employs about 4,200 people worldwide, including approximately 500 researchers and developers. In terms of future direction, Recordati sees continued high potential for growth and expansion, particularly through targeted investments in research and development. The company relies on close cooperation with other partners within the industry and the exploration of new markets and therapeutic areas. Recordati Industria Chimica e Farmaceutica SpA ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Recordati Industria Chimica e Farmaceutica SpA's Equity

Recordati Industria Chimica e Farmaceutica SpA's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Recordati Industria Chimica e Farmaceutica SpA's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Recordati Industria Chimica e Farmaceutica SpA's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Recordati Industria Chimica e Farmaceutica SpA's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Recordati Industria Chimica e Farmaceutica SpA’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Recordati Industria Chimica e Farmaceutica SpA stock

What is the equity of Recordati Industria Chimica e Farmaceutica SpA this year?

Recordati Industria Chimica e Farmaceutica SpA has equity of 1.69 B EUR this year.

What was the equity of Recordati Industria Chimica e Farmaceutica SpA compared to the previous year?

The equity of Recordati Industria Chimica e Farmaceutica SpA has increased/decreased by 9.06% increased compared to the previous year.

What impact does a high equity have on investors of Recordati Industria Chimica e Farmaceutica SpA?

A high equity is advantageous for investors of Recordati Industria Chimica e Farmaceutica SpA as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Recordati Industria Chimica e Farmaceutica SpA?

A low equity can be a risk for investors of Recordati Industria Chimica e Farmaceutica SpA, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Recordati Industria Chimica e Farmaceutica SpA affect the company?

An increase in equity of Recordati Industria Chimica e Farmaceutica SpA can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Recordati Industria Chimica e Farmaceutica SpA affect the company?

A reduction in equity of Recordati Industria Chimica e Farmaceutica SpA can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Recordati Industria Chimica e Farmaceutica SpA?

Some factors that can affect the equity of Recordati Industria Chimica e Farmaceutica SpA include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Recordati Industria Chimica e Farmaceutica SpA so important for investors?

The equity of Recordati Industria Chimica e Farmaceutica SpA is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Recordati Industria Chimica e Farmaceutica SpA take to change the equity?

To change equity, Recordati Industria Chimica e Farmaceutica SpA can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Recordati Industria Chimica e Farmaceutica SpA pay?

Over the past 12 months, Recordati Industria Chimica e Farmaceutica SpA paid a dividend of 1.17 EUR . This corresponds to a dividend yield of about 2.18 %. For the coming 12 months, Recordati Industria Chimica e Farmaceutica SpA is expected to pay a dividend of 1.25 EUR.

What is the dividend yield of Recordati Industria Chimica e Farmaceutica SpA?

The current dividend yield of Recordati Industria Chimica e Farmaceutica SpA is 2.18 %.

When does Recordati Industria Chimica e Farmaceutica SpA pay dividends?

Recordati Industria Chimica e Farmaceutica SpA pays a quarterly dividend. This is distributed in the months of June, December, June, December.

How secure is the dividend of Recordati Industria Chimica e Farmaceutica SpA?

Recordati Industria Chimica e Farmaceutica SpA paid dividends every year for the past 0 years.

What is the dividend of Recordati Industria Chimica e Farmaceutica SpA?

For the upcoming 12 months, dividends amounting to 1.25 EUR are expected. This corresponds to a dividend yield of 2.34 %.

In which sector is Recordati Industria Chimica e Farmaceutica SpA located?

Recordati Industria Chimica e Farmaceutica SpA is assigned to the 'Health' sector.

Wann musste ich die Aktien von Recordati Industria Chimica e Farmaceutica SpA kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Recordati Industria Chimica e Farmaceutica SpA from 11/20/2024 amounting to 0.6 EUR, you needed to have the stock in your portfolio before the ex-date on 11/18/2024.

When did Recordati Industria Chimica e Farmaceutica SpA pay the last dividend?

The last dividend was paid out on 11/20/2024.

What was the dividend of Recordati Industria Chimica e Farmaceutica SpA in the year 2024?

In the year 2024, Recordati Industria Chimica e Farmaceutica SpA distributed 1.17 EUR as dividends.

In which currency does Recordati Industria Chimica e Farmaceutica SpA pay out the dividend?

The dividends of Recordati Industria Chimica e Farmaceutica SpA are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Recordati Industria Chimica e Farmaceutica SpA

Our stock analysis for Recordati Industria Chimica e Farmaceutica SpA Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Recordati Industria Chimica e Farmaceutica SpA Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.